BioCentury
ARTICLE | Company News

Sanofi, Medicines for Malaria Venture deal

August 17, 2015 7:00 AM UTC

Sanofi and Medicines for Malaria Venture (MMV) extended by an undisclosed amount of time a May 2011 deal to identify and develop malaria drug candidates. The extension will allow Phase IIb trials of ...